New award for pegfilgrastim injectables with sandoz INC. Period of performance is april 11, 2020 to april 10, 2021 with four one-year options.

Ended Indefinite Delivery Contract Awarded Last action

Contract number
36E79720D0020
Awardee
Awarding agency
Task orders
0

Award facts

Opportunity
Last date to order 100% complete
IDV ceiling
$26,399,360.75
Award type
Single award
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 4 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

About this IDV

The federal contract IDV is a single-award Indefinite Delivery Contract (IDC) awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Sandoz Inc., a global leader in generic pharmaceuticals and biosimilars. The contract, valued at a ceiling of $26,399,360.75, is for the supply of pegfilgrastim injectables to the VA, Bureau of Prisons, and Indian Health Service.

The contract has a base period of one year and four one-year option periods, with an estimated annual requirement of 7,079 units of either Neulasta, Neulasta Onpro, Udenyca, Fulphila, or Ziextenzo pegfilgrastim injectables. The products will be distributed through the VA Pharmaceutical Prime Vendor program to support the medication needs of veterans, active duty military personnel, federal inmates, and Native American populations served by the healthcare networks. The contract was awarded on an unrestricted basis with no set-asides, utilizing the NAICS code 325412 for pharmaceutical preparation manufacturing.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00018 · Incorporate NDC changes into contract. $0
Add Subcontract Plan P00017 · Incorporate 2025 small business subcontracting plan into contract. $0
Other Administrative Action P00016 · Incorporate 2025 federal ceiling prices into contract. No change to awarded national contract prices. $0
Exercise an Option P00015 · Exercise the fourth option year for pegfilgrastim injections contract 36E79720D0020 with sandoz, INC. With no price changes. $0
Supplemental Agreement for work within scope P00014 · Change timeframe for the submission of quarterly sales reports and cost recovery fee to 30 calendar days after end of each fiscal quarter. $0
Other Administrative Action P00013 · To incorporate a change in the administrative and sales point of contact for sandoz INC. $0
Add Subcontract Plan P00012 · Incorporate sandoz's 2024 small business subcontracting plan into contract. $0
Other Administrative Action P00011 · Incorporation 2024 federal ceiling prices into national contract. No changes to national contract price, as IT is in compliance with new FCP. $0
Other Administrative Action P00010 · Incorporation of drug supply chain security act (DSCSA) language $0
Exercise an Option P00009 · Exercise option year 3 effective april 11, 2023 to april 10, 2024 for pegfilgrastim injectables with sandoz, INC. $0
Add Subcontract Plan P00008 · Modification to incorporate the 2023 small business subcontracting plan. $0
Supplemental Agreement for work within scope P00007 · Modification to incorporate the 2023 FCP. No price changes. $0
Exercise an Option P00006 · Exercise option year 2 for pegfilgrastim with sandoz INC. Period of performance is 4/11/2022 - 4/10/2023. $0
Add Subcontract Plan P00005 · Incorporate the 2022 approved subk plan. $0
Supplemental Agreement for work within scope P00004 · To incorporate the 2022 federal ceiling prices. No changes to national contract price. $0
Exercise an Option P00003 · Exercise the 1ST option year for pegfilgrastim injectable contract 36E79720D0020 with sandoz INC. Period of performance is 4/11/2021 - 4/10/2022. $0
Add Subcontract Plan P00002 · To incorporate the 2021 approved subk plan. Plan effective 1/1/2021 - 12/31/2021 $0
Supplemental Agreement for work within scope P00001 · To incorporate the 2021 federal ceiling prices (FCP). Please note that the current national contract prices are below FCP and are unchanged. $0
Original award $0
Show all 19

Quick answers

Who was awarded contract 36E79720D0020?

36E79720D0020 was awarded to Sandoz Inc. by National Acquisition Center (Headquarters) on April 11, 2020.

How much is contract 36E79720D0020 worth?

36E79720D0020's own ceiling is $26,399,361.

Who can order from contract 36E79720D0020?

36E79720D0020 is a single award indefinite delivery contract.

Was contract 36E79720D0020 competed?

The extent of competition for 36E79720D0020 was full and open competition. The government received 4 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV